April 29, 2025 – Demand for medical care in Southeast Asia is growing at an annual rate of approximately 8-10%, significantly higher than the characteristic rate seen in developed countries. This growth is being driven by rising incomes, an emerging middle-income population tier, and the low level of current spending on healthcare. In particular, demand for medical consumables, including syringes, is growing rapidly due to rising uptake of disposables in healthcare, driven by concerns around sanitization, the need for higher efficiency in operations, and adoption of international standards and practices.
Oneject is a dominant player in Auto-Disable Syringes (disposable syringes with a special safety mechanism to prevent re-use) in Indonesia, with its products meeting the standards specified by the World Health Organization and supplied to a number of international markets.
There is an acute need for medical consumables manufacturers in the context of promoting self-sufficiency in medical devices and equipment. Oneject is accordingly expanding its manufacturing capabilities and knowledge with the aim of diversifying its portfolio to include adjacent product categories and consumables.
As a strategic, long-term business partner, MGCA is committed to supporting the development of Oneject’s product portfolio, its international expansion, and its strategic goal of becoming a leading manufacturer of medical devices and consumables in Southeast Asia. This investment in Oneject represents MGCA’s first transaction in the healthcare sector in Southeast Asia, and its third investment overall.
Marubeni established the Next Generation Corporate Development Division in 2022 to capture the growth of consumer businesses in Southeast Asia and the United States, with the aim of thereby building a new consumer platform to drive Marubeni’s growth through 2030 and beyond. Marubeni and MGCA remain committed to making further value-enhancing investments within the healthcare sector and supporting investee companies.
| Marubeni Growth Capital Asia Pte. Ltd. Overview | |
| Head Office: | 8 Marina View, #14-03 Asia Square Tower 1, Singapore 018960 |
| Representative: | Bharat Sarma |
| Website: | https://www.marubenigrowthcapital.com |
| Business Description: | Investment in consumer related businesses in Southeast Asia focused on next generation consumers |
| PT One-ject Indonesia Overview | |
| Head Office: | Jalan Olympic Raya Kavling B-9, Sentul, Bogor, 16810, Indonesia |
| Representative: | Jahja Tear Tjahjana |
| Website: | https://oneject.co.id/ |
| Business Description: | Manufacture and sale of medical consumables and devices, and provision of services relating to medical equipment |
About Oneject
Oneject Indonesia, established in 2003, is a leading medical device manufacturer in Indonesia, with a product portfolio covering Smart Syringes, Infusion Therapy, Blood Collection, Blood Purification and Dialysis Care, In Vitro Diagnostics, and Radiology. Oneject Indonesia has developed innovations in medical devices and consumables and currently has growing presence in Asia, as well as developed countries.
Oneject Indonesia is dedicated to delivering superior products and continuously drive innovation through cutting-edge technology ensuring safe, comfortable, and reliable medical devices and consumables for both patients and healthcare workers.